CA2288840A1 - Integrin-targeting vectors having transfection activity - Google Patents

Integrin-targeting vectors having transfection activity Download PDF

Info

Publication number
CA2288840A1
CA2288840A1 CA002288840A CA2288840A CA2288840A1 CA 2288840 A1 CA2288840 A1 CA 2288840A1 CA 002288840 A CA002288840 A CA 002288840A CA 2288840 A CA2288840 A CA 2288840A CA 2288840 A1 CA2288840 A1 CA 2288840A1
Authority
CA
Canada
Prior art keywords
complex
nucleic acid
component
integrin
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002288840A
Other languages
English (en)
French (fr)
Inventor
Stephen Hart
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ICH Productions Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2288840A1 publication Critical patent/CA2288840A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/906—Drug delivery
    • Y10S977/907—Liposome

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Compression Or Coding Systems Of Tv Signals (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Electrotherapy Devices (AREA)
CA002288840A 1997-05-29 1998-05-29 Integrin-targeting vectors having transfection activity Abandoned CA2288840A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9711115.7A GB9711115D0 (en) 1997-05-29 1997-05-29 Integrin-targeting vectors having enhanced transfection activity
GB9711115.7 1997-05-29
PCT/GB1998/001577 WO1998054347A1 (en) 1997-05-29 1998-05-29 Integrin-targeting vectors having transfection activity

Publications (1)

Publication Number Publication Date
CA2288840A1 true CA2288840A1 (en) 1998-12-03

Family

ID=10813246

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002288840A Abandoned CA2288840A1 (en) 1997-05-29 1998-05-29 Integrin-targeting vectors having transfection activity

Country Status (9)

Country Link
US (2) US6458026B1 (cg-RX-API-DMAC7.html)
EP (1) EP1003898B1 (cg-RX-API-DMAC7.html)
JP (1) JP4293292B2 (cg-RX-API-DMAC7.html)
AT (1) ATE301722T1 (cg-RX-API-DMAC7.html)
AU (1) AU7667398A (cg-RX-API-DMAC7.html)
CA (1) CA2288840A1 (cg-RX-API-DMAC7.html)
DE (1) DE69831156T2 (cg-RX-API-DMAC7.html)
GB (1) GB9711115D0 (cg-RX-API-DMAC7.html)
WO (1) WO1998054347A1 (cg-RX-API-DMAC7.html)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5043271B2 (ja) 2000-04-12 2012-10-10 ジーイー・ヘルスケア・アクスイェ・セルスカプ ペプチドベースの化合物
EP1285081A2 (en) * 2000-05-30 2003-02-26 ICH Productions Limited Improved methods of transfection
EP1178117A1 (en) * 2000-08-02 2002-02-06 Erasmus Universiteit Rotterdam Targeting through integrins
NO20004795D0 (no) 2000-09-26 2000-09-26 Nycomed Imaging As Peptidbaserte forbindelser
US8613907B2 (en) * 2000-10-12 2013-12-24 University Of Rochester Compositions that inhibit proliferation of cancer cells
GB0106315D0 (en) 2001-03-14 2001-05-02 Ich Productions Ltd Transfection complexes
KR100904954B1 (ko) * 2001-05-30 2009-06-26 더 스크립스 리서치 인스티튜트 핵산용 전달 시스템
CN1622830A (zh) 2001-07-10 2005-06-01 安盛药业有限公司 肽基化合物
GB0210538D0 (en) * 2002-05-08 2002-06-19 Univ London Lipids and gene delivery
US7598421B2 (en) 2002-05-08 2009-10-06 Ucl Biomedica Plc Materials for the delivery of biologically-active material to cells
KR20060015534A (ko) * 2003-04-25 2006-02-17 더 펜 스테이트 리서치 파운데이션 성장 억제, 지질 유래된 생활성 화합물의 전신 전달을 위한방법 및 시스템
GB0313132D0 (en) * 2003-06-06 2003-07-09 Ich Productions Ltd Peptide ligands
AU2004297533B2 (en) 2003-10-24 2010-04-29 Gencia Corporation Methods and compositions for delivering polynucleotides
US8133733B2 (en) 2003-10-24 2012-03-13 Gencia Corporation Nonviral vectors for delivering polynucleotides to target tissues
US20090123468A1 (en) 2003-10-24 2009-05-14 Gencia Corporation Transducible polypeptides for modifying metabolism
US8062891B2 (en) 2003-10-24 2011-11-22 Gencia Corporation Nonviral vectors for delivering polynucleotides to plants
US8507277B2 (en) 2003-10-24 2013-08-13 Gencia Corporation Nonviral vectors for delivering polynucleotides
MX2008009970A (es) * 2006-02-01 2008-11-19 Univ Johns Hopkins Conjugados de polipeptido-acido nucleico para inmunoprofilaxis o inmunoterapia para desordenes neoplasicos o infecciosos.
US10034674B2 (en) * 2006-02-02 2018-07-31 Steven C Chudik Universal anterior cruciate ligament repair and reconstruction system
GB0610636D0 (en) 2006-05-30 2006-07-05 Univ London Materials and complexes for the delivery of biologically-active material to cells
EP2178896A1 (en) * 2007-07-31 2010-04-28 The Johns Hopkins University Polypeptide-nucleic acid conjugate for immunoprophylaxis or immunotherapy for neoplastic or infectious disorders
WO2009094634A1 (en) 2008-01-24 2009-07-30 Esperance Pharmaceuticals Lytic domain fusion constructs and methods of making and using same
JP2012513589A (ja) 2008-12-23 2012-06-14 ジーイー・ヘルスケア・リミテッド 骨髄イメージング剤としての99mTc−ペプチド系化合物の応用
EP4710943A3 (en) 2015-08-28 2026-04-29 Molecular Transfer, Inc. Transfection complexes and methods of using the same
WO2017151733A1 (en) 2016-03-01 2017-09-08 Molecular Transfer, Inc. Plant virus movement proteins and methods of using the same
GB201604235D0 (en) 2016-03-11 2016-04-27 Ucl Business Plc Lipids and complexes for the delivery of biologically-active material to cells
GB201803419D0 (en) * 2018-03-02 2018-04-18 Ucl Business Plc Complex for the delivery of cas9 proteins guide RNA to cells
US12649000B2 (en) 2018-03-19 2026-06-09 Algipharma As Use of alginate oligomers to enhance the translocation of micro/nanoparticles across mucus layers

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5981478A (en) * 1993-11-24 1999-11-09 La Jolla Cancer Research Foundation Integrin-binding peptides
DE69536153D1 (de) 1994-11-17 2011-05-05 Ich Productions Ltd Internalisierung von dna, unter verwendung von konjugaten des poly-l-lysins und eines peptidligands des integrin-rezeptors
WO1996040961A1 (en) 1995-06-07 1996-12-19 Life Technologies, Inc. Peptide-enhanced cationic lipid transfections
US5908777A (en) * 1995-06-23 1999-06-01 University Of Pittsburgh Lipidic vector for nucleic acid delivery

Also Published As

Publication number Publication date
EP1003898B1 (en) 2005-08-10
DE69831156T2 (de) 2006-06-08
DE69831156D1 (de) 2005-09-15
US6458026B1 (en) 2002-10-01
GB9711115D0 (en) 1997-07-23
ATE301722T1 (de) 2005-08-15
JP4293292B2 (ja) 2009-07-08
EP1003898A1 (en) 2000-05-31
US20020042384A1 (en) 2002-04-11
WO1998054347A1 (en) 1998-12-03
AU7667398A (en) 1998-12-30
US20030013644A1 (en) 2003-01-16
JP2002502243A (ja) 2002-01-22

Similar Documents

Publication Publication Date Title
EP1003898B1 (en) Integrin-targeting vectors having transfection activity
Hart et al. Lipid-mediated enhancement of transfection by a nonviral integrin-targeting vector
Perales et al. An evaluation of receptor‐mediated gene transfer using synthetic DNA‐ligand complexes
Remy et al. Targeted gene transfer into hepatoma cells with lipopolyamine-condensed DNA particles presenting galactose ligands: a stage toward artificial viruses.
CA2163364C (en) Self-assembling polynucleotide delivery system comprising dendrimer polycations
Pack et al. Design and development of polymers for gene delivery
US5908777A (en) Lipidic vector for nucleic acid delivery
JPH10505242A (ja) キメラペントンベースタンパク質を含有する組換えアデノウイルス
Kabanov et al. Efficient transformation of mammalian cells using DNA interpolyelectrolyte complexes with carbon chain polycations
JP2000505788A (ja) 巨大分子送達用の親油性ペプチド
Welser et al. Gene delivery using ternary lipopolyplexes incorporating branched cationic peptides: the role of peptide sequence and branching
EP1053024A1 (en) Liposome fusion and delivery vehicle
AU8714898A (en) Biologically tolerated low molecular weight polyethylenimines
Müller et al. Highly efficient transduction of endothelial cells by targeted artificial virus-like particles
Anwer et al. Peptide-mediated gene transfer of cationic lipid/plasmid DNA complexes to endothelial cells
Mustapa et al. Stabilized integrin-targeting ternary LPD (lipopolyplex) vectors for gene delivery designed to disassemble within the target cell
WO2001092542A2 (en) Integrin-targeting vectors having enhanced transfection activity
US20040014217A1 (en) Methods of transfection
Hart Use of adhesion molecules for gene delivery
Wagner Functional polymer conjugates for medicinal nucleic acid delivery
Chowdhury Self-assembly of DNA and cell-adhesive proteins onto pH-sensitive inorganic crystals for precise and efficient transgene delivery
EP1178117A1 (en) Targeting through integrins
Scheule et al. Liposome delivery
Hart et al. Integrin-Mediated Gene Delivery
Santhakumaran et al. Nanotechnology in Nonviral Gene Delivery

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued